Patents
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
10/2003
10/30/2003US20030204086 Novel heterocyclic amide derivatives
10/29/2003EP1357111A1 Pyridone derivative having affinity for cannabinoid 2-type receptor
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355901A2 1,1-DISUBSTITUTED CYCLIC INHIBITORS OF MATRIX METALLOPROTEASE AND TNF-$g(a)
10/29/2003EP1355878A2 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
10/29/2003EP1355647A2 The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
10/29/2003EP1355639A2 Substituted carbostyril derivatives as 5-ht1a receptor subtype agonists
10/29/2003EP1153920B1 Quinoline derivatives and quinazoline derivatives
10/29/2003EP1112256B1 Cyclohexenonquinolinoyl-derivatives as herbicidal agents
10/29/2003EP0843663B9 4-aryl-thio-pyridin-2(1h)-ones, drugs containing same, and uses thereof for treating hiv-related diseases
10/29/2003EP0633881B1 Amine derivatives of oxo- and hydroxy-substitued hydrocarbons
10/29/2003CN1452614A Arylpiperazine derivs. and their use as psychotropic agents
10/29/2003CN1125815C Method for synthesis of quinoline derivatives
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638947 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/28/2003US6638945 Quinoline derivatives as inhibitors of MEK enzymes
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638929 Tricyclic protein kinase inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/25/2003CA2383390A1 Easily removalbe reagents for the mitsunobu reaction
10/23/2003WO2003087088A2 (condensed) pyrimidone and (condensed) pyridone compounds, processes for their preparation, and pharmaceutical compositions containing them
10/23/2003WO2003087066A1 α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086466A1 Novel thrombomodulin expression promoters
10/23/2003WO2003086402A1 ANHYDROUS CRYSTALLINE FORMS I AND II OF 1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL) 4-OXO-l, 4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID (GATIFLOXACIN)
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003US20030199696 Heterocyclic imines such as 3-(3-quinolyl)-2-propyn-1-ol morpholine carbamate, used as chemical intermediates for antibiotics such as clarithromycin
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199560 Bisaryl compound and medicament for cancer treatment comprising the same
10/23/2003US20030199540 Fluoroalkyoxybenzylamino derivatives of nitrogen containing heterocycles
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199482 Anticholesterol agents; a drug mixture for treating hypercholesterolemia comprising an apical sodium co-dependent bile acid transport inhibitor, enzyme inhibitors of a cyclooxygenase-2
10/23/2003US20030197183 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds
10/23/2003CA2481308A1 Anhydrous crystalline forms i and ii of 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl) 4-oxo-1, 4-dihydroquinoline-3-carboxylic acid (gatifloxacin)
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354878A2 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
10/22/2003EP1354865A1 Process for the preparation of aromatic aldehydes via ozonolysis of aromatic alkenes
10/22/2003EP1353915A2 Therapeutic chroman compounds
10/22/2003EP1353914A2 Therapeutic chromone compounds
10/22/2003EP1353913A2 Therapeutic heterocyclic compounds
10/22/2003EP1353907A2 Phosphodiesterase 4 inhibitors
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
10/22/2003EP1353897A1 Method for producing dtpa monoamides
10/22/2003EP1178966B1 Quinoline derivatives as inhibitors of mek enzymes
10/22/2003EP0800519B1 Steroid receptor modulator compounds and methods
10/22/2003CN1450056A Novel process for preparing Aripiprazole
10/22/2003CN1125144C Azo comounds and process for producing the same
10/22/2003CN1125073C Process for preparing (-) pyridobenzoxazine carboxylic acid derviatives
10/22/2003CN1125044C Novel prostaglandin synthase inhibitors
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/21/2003US6635641 For treating cancer and other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic retinopathy, neovascular glaucoma, rheumatoid arthritis, psoriasis
10/21/2003US6635250 Use of certain metalloproteinase inhibitors for treating nerve disorders mediated by nucleus pulpsus
10/21/2003CA2003480C Fungicides
10/16/2003WO2003084927A1 Haloalkenes, process for production thereof, and pest controllers containing the same
10/16/2003WO2003037311A3 Method for treating retroviral infections
10/16/2003WO2003010144A3 A process for synthesis of fluoroquinolonic derivatives
10/16/2003WO2002100849A3 Novel nitriles useful as reversible inhibitors of cysteine proteases
10/16/2003WO2002076939A3 Cysteine protease inhibitors
10/16/2003US20030195226 Nitrogen compounds such as pyridine-3-carbaldehyde, O-(((4-undecyloxy-phenyl)amino)carbonyl)oxime, used for prophylaxis of vision, eating or cardiovascular disorders, and as anxiolytic and antiemetic agents
10/16/2003US20030195219 Hybrid 2-aminotetralin and aryl-substituted piperazine compounds and their use in altering cns activity
10/16/2003US20030195204 Quinoline derivatives as NK3 antagonists
10/16/2003US20030195201 Vanilloid receptor ligands and their use in treatments
10/16/2003US20030195200 Compounds, their preparation and use
10/16/2003US20030195194 For therapy of immune related responses, tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis
10/16/2003US20030195188 Pyridine and quinoline derivatives
10/16/2003US20030195187 For therapy of obesity or type II diabetes
10/15/2003EP1352650A1 Inhibitors against the production and release of inflammatory cytokines
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351940A1 Substituted quinolines for the treatment of protozoan and retrovirus co-infections
10/15/2003EP1351688A1 Urotensin-ii receptor antagonists
10/15/2003EP1351687A2 Urotensin-ii receptor antagonists
10/15/2003CN1449640A Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such
10/15/2003CN1449384A Novel ester or amide derivatives
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1448389A L-amino acid acyl-( 8-quinolyl ) amine platinum (II) complex and prep. and use thereof
10/15/2003CN1448388A L-amino acid acyl -( 8-quinolyl ) amine, its derivative and prep. thereof
10/15/2003CN1124264C Process for preparing quinolone- and naphthyridonecarboxylic acids and esters thereof
10/14/2003US6632919 Bind Watson-Crick base pairs in a double helix; specific for thymidine
10/14/2003US6632840 Monoacyl-substituted guanidines, a process for their preparation, their use as a medicament or diagnostic aid, and pharmaceutical compositions containing them
10/14/2003US6632826 Carbocyclic HIV protease inhibitors
10/14/2003US6632825 Picornaviral 3C protease enzyme inhibitors; amide ester or amide acid derivatives
10/14/2003US6632810 Cyclic diamine compound with condensed-ring groups
10/09/2003WO2003082827A1 Quinoline and isoquinoline derivatives, method for the production thereof and use thereof as anti-inflammatory agents
10/09/2003WO2003082350A2 Radiolabelled quinoline and quinolinone derivatives and their use as metabotropic glutamate receptor ligands
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191166 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
10/09/2003US20030191069 2-oxoquinoline compounds and pharmaceutical uses thereof
10/09/2003US20030191027 Herbicides
10/08/2003CN1447797A New process for preparing quinolone-carboxylic acid
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/07/2003US6630591 Process for the preparation of quinolylpropenal
10/07/2003US6630589 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630489 Quinoline derivatives as tyrosine kinase inhibitors
10/07/2003US6630482 CFTR channel activator compounds and pharmaceutical compositions containing same
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003CA2223418C Polyoxyhydrocarbyl related products and methods for fluorescence assays